Status:
UNKNOWN
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
Lead Sponsor:
NSABP Foundation Inc
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
35+ years
Brief Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to c...
Detailed Description
OBJECTIVES: Primary * To identify genes associated with breast events (i.e., the occurrence of invasive breast cancer or ductal carcinoma in situ), in terms of single-nucleotide polymorphisms (SNPs)...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Meets 1 of the following criteria:
- Previously treated on the NSABP-P-1 Breast Cancer Prevention clinical trial
- Caucasian women that did or did not experience an invasive breast cancer or ductal carcinoma in situ (DCIS)
- At least 50 years of age at time of entry to P-1
- Previously treated on the NSABP-P-2 Breast Cancer Prevention clinical trial
- Caucasian women that did or did not experience an invasive breast cancer or DCIS
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Postmenopausal status
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1881 Patients enrolled
Trial Details
Trial ID
NCT00967239
Start Date
April 1 2009
Last Update
May 8 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.